COVID-19 prolongado: ¿un nuevo factor de riesgo para enfermedades autoinmunes y linfoma?
Texto completo:
PDFReferencias
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-93. DOI: https://doi.org/10.1001/jama.2020.12839
Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74. DOI: https://doi.org/10.1016/j.ebiom.2021.103722
Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10(6):763. DOI: https://doi.org/10.3390/pathogens10060763
Gaspar-RodrÃguez A, Padilla-González A, Rivera-Toledo E. Coronavirus persistence in human respiratory tract and cell culture: An overview. The Brazilian Journal of Infectious Diseases. 2021;25(5):101632. DOI: https://doi.org/10.1016/j.bjid.2021.101632
Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):1-7. DOI: https://doi.org/10.1038/s41590-021-01113-x
Schiffner J, Backhaus I, Rimmele J, Schulz S, Möhlenkamp T, Klemens JM, et al. Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection. Front Public Health. 2021;9:732-87. DOI: https://doi.org/10.3389/fpubh.2021.732787
Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for a tailored therapy. European Respiratory Journal. 2021;59(2):2102245. DOI: https://doi.org/10.1183/13993003.02245-2021
Chen J, Dai L, Barrett L, Post SR, Qin Z. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. Commun Biol. 2021;4(1):682. DOI: https://doi.org/10.1038/s42003-021-02220-z
Shannon-Lowe C, Rickinson AB, Bell AI. Epstein–Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160271. DOI: https://doi.org/10.1098/rstb.2016.0271
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2023 JUAN BRACAMONTE HERNANDEZ, Rafael Martin de Jesus Pichardo Pichardo Rodriguez, Marcos Saavedra Velazco Saavedra Velazco, Liz Córdova Cueva, De la De la cruz Vargas
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.